Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To obtain information on clinical practices for patients treated by Aptivus in real life

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Tipranavir

Criteria

Inclusion Criteria:

• HIV positive patients for whom Aptivus treatment is initiated by their physician

• Aptivus SCP respect

Exclusion Criteria:

None if the inclusion criteria are respected: observational study